The best stocks to watch tomorrow start with the opening bell of earnings season. JPMorgan, Goldman Sachs, Citigroup and Wells Fargo all report before the open on Tuesday, Oct. 13, with UnitedHealth on the same morning slate. Around that, Monday handed traders a memory-chip rout, a $1.3 billion quantum acquisition, a software double upgrade and a takeover tape in an auto-insurance software name. Here are the top stocks to watch tomorrow, every one with full levels, a bull and bear case and a forecast. For the prior session’s setups, see TNN’s Oct. 12 stocks to watch and penny stocks under $3.
Today’s Market Snapshot: A Split Tape Before the Bank Earnings Wave
| Index / Asset | Monday, Oct. 12 Close | Change |
|---|---|---|
| S&P 500 | 7,807.24 | -0.06% |
| Dow Jones Industrial Average | 51,850.55 | +0.38% |
| Nasdaq Composite | 27,245.90 | -0.44% |
| Russell 2000 | 2,794.48 | -0.45% |
| VIX | 15.21 | +2.49% |
| WTI crude (Nov) | $93.22 | +1.49% |
| 10-year Treasury yield | 5.24% | Flat |
The Dow was the only major index to finish higher as memory stocks dragged the Nasdaq. Index and oil figures are from Vista Partners’ market recap.
Macro drivers for Tuesday:
- Inflation: September CPI lands Wednesday. Economists expect 3.6% headline and 2.4% core, so hot numbers could revive rate-hike talk after September’s Fed move to 3.75%-4.00%.
- Breadth: The bull market turned four, but roughly 75% of S&P 500 stocks finished September lower, which is why single-stock catalysts matter.
- Energy: Crude rose again on Middle East supply worries, a cost pressure for the inflation debate.
Data note: Closing prices are Oct. 12 official closes where stated (JPM, GS, UNH, IONQ, CRM, MU, IREN, CCC). ASTS and SOC lack a verified Oct. 12 final print, so we show the last confirmed close plus Monday’s reported move. Support and resistance are analytical zones from recent highs, lows and moving averages, not guaranteed targets. “n/v” means not verified.
1. JPMorgan Chase (JPM) | Earnings Before Market Open | Closed $334.30 (+0.39%)
The Bank That Sets the Tone for Every Lender in America
Catalyst: JPMorgan reports around 7:00 a.m. ET with a call at 8:30. The Street wants roughly $5.93 a share on about $51.2B of revenue versus $5.07 a year ago, per MarketBeat. Options price a ±3.6% move.
Latest news: Management guided investment banking fees and markets revenue up by the mid-to-high teens, per Admirals’ bank-season preview, while a 5.24% 10-year yield raises deposit-cost and bond-mark questions.
Technicals: JPM closed just above its 10-day average zone near $334, still under its ~$350 50-day area and the $366.50 record from Aug. 13.
Fundamentals: Q2 adjusted EPS was $6.14 versus $5.59 expected, and 2026 net interest income is guided to about $105.5B.
| Metric | Data |
|---|---|
| Last close / prior close | $334.30 (+$1.31, +0.39%) / $332.99 |
| Day’s range | $333.55 – $336.34 |
| 52-week range | $279.10 – $366.50 |
| Market cap | ~$888.6B |
| P/E (TTM / forward) | 14.35 / 13.65 |
| Dividend | $6.60 a year (1.97%) |
| Volume | 5.68M (pre-report; average n/v) |
| YTD (derived from $322.22 year-end) | About +3.7% |
| Analysts | Buy (25); average target $372.14 (+11%) |
| Implied earnings move | ±3.6% (about $322 – $346) |
| Support (S1 / S2 / S3) | $333.55 / $325 / $322.14 (200-day) |
| Resistance (R1 / R2 / R3) | $336.34 / $345 / $350 |
Bull case: Eight straight EPS beats, guided fee growth and a $50B buyback program.
Bear case: Shares fell after four of the last five reports, expense guidance rose to ~$107.5B, and Q2’s reported EPS included one-off gains.
What to watch:
- Markets and fee growth against the mid-to-high-teens guide
- 2027 net interest income and expense commentary
- Reserve builds and card charge-offs near the 3.2% guide
Forecast: A clean beat with firm NII guidance targets $345 – $350. A cost or deposit surprise that loses $322 puts $315 in play.
Why this matters: JPM is the sector’s report card. Banks just posted their worst month against the S&P 500 since 1990, per Admirals’ summary of Truist research, so one print can reset the group.
2. Goldman Sachs (GS) | Earnings Before Market Open | Closed $893.95 (-0.15%)
Twelve Straight Beats, One Very Wide Estimate Range
Catalyst: Goldman reports about 7:30 a.m. ET. FactSet-based estimates sit near $13.03 – $13.07 a share on ~$16.7B of revenue against $12.25 last year, but some models run as high as $16.42, so “beat” is a moving target.
Latest news: The CEO flagged softer fixed-income trading and higher costs in September, per Admirals’ preview. Goldman has topped estimates 12 straight quarters, and TD Cowen just initiated at Buy with a $1,050 target.
Technicals: GS trades about 22% below its $1,153.99 high and under its 50-day ($989.93) and 200-day ($959.89) averages.
Fundamentals: TTM revenue is $67.6B (+23.3%) and net income $20.0B (+34.8%).
| Metric | Data |
|---|---|
| Last close / prior close | $893.95 (-$1.37, -0.15%) / $895.32 |
| Day’s range | $887.78 – $902.29 |
| 52-week range | $740.01 – $1,153.99 |
| Market cap | $270.66B |
| P/E (TTM / forward) | 13.83 / 13.88 |
| Dividend | $20.00 a year (2.24%) |
| Volume | 2.12M (pre-report; average n/v) |
| YTD (derived from $879.00 year-end) | About +1.7% |
| Analysts | Hold (26); average target $1,069.10 (+19.6%) |
| Implied earnings move | ±4.3% – 4.7% |
| Support (S1 / S2 / S3) | $887.78 / $868.52 / ~$853 |
| Resistance (R1 / R2 / R3) | $902.29 / $905 – $913 / $936 – $967 |
Bull case: Record Q2 equities trading ($7.4B), a five-year-high banking backlog and a 13.8x forward P/E.
Bear case: Quieter deal flow after a 41% quarterly drop in global M&A, softer FICC and succession headlines around a $500M+ executive award.
What to watch:
- Equities versus fixed-income trading revenue
- Advisory fees and backlog conversion
- Non-compensation expenses
Forecast: A hold above $887 with strong equities favors a test of $905 – $913. A miss that breaks $868 opens the ~$853 zone.
Why this matters: Goldman is the purest read on dealmaking, the same pipeline that includes the reported AI IPO calendar.
3. UnitedHealth Group (UNH) | Earnings Before Market Open | Closed $378.52 (-0.21%)
A Stock That Moved Up to 20% on Earnings Day Last Time
Catalyst: UnitedHealth reports before the open with consensus near $4.12 – $4.15 a share on ~$111.3B of revenue versus $2.92 a year ago. Options imply roughly ±6.6% to 7.1%.
Latest news: The full-year adjusted EPS guide is $19.50 – $20.00, and the medical care ratio guide is 88.1% (Q2 was 86.7%). Investing.com’s preview flags a seasonally higher Q3 ratio. A Texas AG probe is an added headline risk, and the Medicare Stars shake-up we covered in our Oct. 9 setups is still in play.
Technicals: UNH sits ~18% under its $461.62 high and held a $373.67 intraday low on Monday.
Fundamentals: TTM EPS is $15.53 (-32.8%) on $450.5B of revenue.
| Metric | Data |
|---|---|
| Last close / prior close | $378.52 (-$0.78, -0.21%) / $379.30 |
| Day’s range | $373.67 – $382.98 |
| 52-week range | $255.97 – $461.62 |
| Market cap | $339.76B |
| P/E (TTM / forward) | 24.37 / 17.76 |
| Dividend | $9.28 a year (2.45%) |
| Volume | 5.91M (pre-report; average n/v) |
| Versus 52-week high | About -18% |
| Analysts | Buy (26); average target $480.60 (+27%) |
| Implied earnings move | ±6.6% (about $354 – $404) |
| Support (S1 / S2 / S3) | $373.67 / ~$354 / $340 |
| Resistance (R1 / R2 / R3) | $382.98 / ~$404 / $431.34 |
Bull case: Four straight EPS beats, a +10.3% reaction in July and a 17.8x forward P/E.
Bear case: Revenue is flat, the stock fell about 20% after its January report despite a beat, and guidance cuts would revive that fear.
What to watch:
- Medical care ratio against the 88.1% guide
- Any change to the $19.50 – $20.00 EPS range
- 2027 outlook and Optum Health margins
Forecast: Intact guidance targets $404 – $431. A cut or ratio spike likely retests $354 – $340.
Why this matters: UNH is the health-insurance bellwether. A clean quarter would help the whole managed-care group.
4. IREN Ltd (IREN) | AI Cloud Deal Report | Closed $34.80 (-1.11%)
The Anthropic Pop That Faded Into the Close
Catalyst: IREN jumped more than 5% premarket after The Information reported a multi-year AI cloud deal with Anthropic, then gave it back. Neither company has confirmed terms.
Latest news: The stock had slid ~16% last week, as detailed in TNN’s IREN forecast. Schaeffer’s notes a 14-day RSI near 16.9.
Technicals: Deeply oversold, below the 200-day average, with $35 acting as repeated support and $50 as overhead resistance.
Fundamentals: TTM EPS is -$2.22, debt-to-equity ~1.8x, and contracted revenue includes a ~$9.7B Microsoft agreement.
| Metric | Data |
|---|---|
| Last close / prior close | $34.80 (-$0.39, -1.11%) / $35.19 |
| Intraday high | Nearly $37 |
| 52-week range | $28.93 – $76.87 |
| Market cap | ~$13.7B (derived, ~394M shares) |
| P/E / Dividend | n/a (loss-making) / None |
| Volume vs. average | 48.5M vs. 43.0M (about +13%) |
| Versus 52-week high | About -55% |
| Beta | 4.27 |
| Analysts | Buy (20); average target $78.14 (+125%) |
| Support (S1 / S2 / S3) | $34.64 / $33.72 / $28.93 |
| Resistance (R1 / R2 / R3) | ~$37.00 / $38.35 / $41.28 |
Bull case: A confirmed marquee customer would convert rumor into backlog, and targets sit far above the price.
Bear case: Unconfirmed headlines have faded before, dilution risk looms and a beta above 4 means violent swings.
What to watch:
- Any formal Anthropic announcement
- A hold above $34.64 versus a break toward $33.72
- Volume against the ~43M average
Forecast: Above $37, the $38.35 gap level is next. Below $34.64, expect $33.72, then $32.81.
Why this matters: IREN trades as a pure sentiment gauge for AI-infrastructure financing, and confirmation, not rumor, is the missing piece.
5. IonQ (IONQ) | $1.3B Elisity Deal | Closed $36.27 (-9.07%)
Quantum Buys Cybersecurity, and Shareholders Flinch
Catalyst: IonQ agreed to buy Elisity in an all-stock deal worth up to $1.3B, including up to $150M of earnouts, adding zero-trust security to its post-quantum cryptography push. Closing is expected in Q4.
Latest news: The share exchange uses a reference price band of $33.07 – $49.61, and the market is pricing dilution. Rosenblatt reiterated Buy with a $100 target.
Technicals: IONQ gapped from $39.89 and closed near the low end of a $35.89 – $38.81 range on heavy volume.
Fundamentals: TTM EPS is -$3.43 and the next report is Nov. 4.
| Metric | Data |
|---|---|
| Last close / prior close | $36.27 (-$3.62, -9.07%) / $39.89 |
| Day’s range | $35.89 – $38.81 |
| 52-week range | $25.89 – $84.64 |
| Market cap | $14.69B |
| P/E / Dividend | n/a (loss-making) / None |
| Volume vs. average | 31.7M vs. 21.2M (about 1.5x) |
| Versus 52-week high | About -57% |
| Beta | 3.36 |
| Analysts | Strong Buy (14); average target $66.63 (+84%) |
| Support (S1 / S2 / S3) | $35.89 / $33.07 / $25.89 |
| Resistance (R1 / R2 / R3) | $38.81 / $39.89 / $49.61 |
Bull case: A security product line and bank targets of $52 – $100 on the 2027 roadmap.
Bear case: Share-funded M&A dilutes holders, integration is unproven and the company is unprofitable.
What to watch:
- A hold of $35.89 on follow-through selling
- A rebound into the $39.89 gap
- Sector moves in other quantum names
Forecast: Above $38.81, the gap fill at $39.89 is likely. A close under $35.89 points to $33.07.
Why this matters: IonQ is testing whether the market rewards quantum companies for buying revenue.
6. Salesforce (CRM) | BofA Double Upgrade | Closed $233.92 (+2.09%)
From “Underperform” to “Buy”: Wall Street’s Sharpest AI U-Turn
Catalyst: Bank of America upgraded CRM two notches to Buy and lifted its target to $285 from $160, arguing AI deepens dependence on enterprise platforms.
Latest news: Shares touched $240.90 (+5.1%) before trimming gains. BMO’s target is $285 and Argus’ is $300.
Technicals: CRM defended Friday’s $229.13 close and faces the $240.90 intraday high.
Fundamentals: The stock trades near 14x forward earnings versus ServiceNow’s 28x, per 24/7 Wall St., and is still down roughly 11% in 2026.
| Metric | Data |
|---|---|
| Last close / prior close | $233.92 (+$4.79, +2.09%) / $229.13 |
| Intraday high | $240.90 (+5.1%) |
| 52-week range / volume | n/v / n/v |
| Market cap | ~$220B (derived) |
| P/E | ~14x forward |
| Dividend | Small (~0.7%, est.) |
| YTD | About -11% |
| Analysts | Moderate Buy (36 of 51 Buy or better); consensus target ~$278 – $283 |
| Support (S1 / S2 / S3) | $229.13 / $225 / $220 |
| Resistance (R1 / R2 / R3) | $240.90 / $250 / ~$278 (consensus target) |
Bull case: Stronger free cash flow, a cheap multiple and improving Agentforce monetization.
Bear case: AI revenue is still small, adoption could lag and the stock gave back half its intraday gain.
What to watch:
- A close above $240.90
- Other software names (ServiceNow rose ~3%)
- CPI on Wednesday
Forecast: A close above $240.90 targets $250. Failure at $229 reopens $225.
Why this matters: If the “AI eats software” trade is easing, depressed software leaders could lead a catch-up rally.
7. Micron Technology (MU) | CXMT Memory Rout | Closed $989.04 (-3.88%)
A $100 Billion Memory Wipeout and a Break Below $1,000
Catalyst: China’s CXMT flagged a denser DRAM design with server memory planned by year-end. Micron, SK Hynix and Sandisk lost about $108B of value in the morning.
Latest news: Micron closed below $1,000 for a third straight loss. Reports note CXMT still trails leaders by generations, which tempers the fear. For Micron’s licensing angle, see TNN’s NLST report.
Technicals: Micron failed at ~$1,029 and is testing the psychological $1,000 line; MACD is neutral.
Fundamentals: Year-to-date, shares are up ~245% from about $286.
| Metric | Data |
|---|---|
| Last close / prior close | $989.04 (-3.88%) / ~$1,029 (derived) |
| Intraday low | ~$984 |
| 52-week range | n/v (about 18% below its high) |
| Market cap | ~$1.1T (derived) |
| P/E / Dividend | n/v / Token (<0.1%) |
| Volume | Heavy; average n/v |
| YTD | About +245% |
| Analysts | Buy; last published consensus target above $1,200 |
| Support (S1 / S2 / S3) | ~$984 / $950 / $900 |
| Resistance (R1 / R2 / R3) | $1,003 / ~$1,029 / ~$1,045 |
Bull case: AI memory demand, tight supply and a tripled stock with strong earnings power.
Bear case: Rising Chinese capacity could ease pricing, the stock is extended and a Taiwan union strike vote adds noise.
What to watch:
- A reclaim of $1,000
- Follow-through in Sandisk, SK Hynix and Samsung
- Fresh CXMT product details
Forecast: Above $1,003 the gap to $1,029 reopens. Under $984, $950 is the next area.
Why this matters: Memory leads AI-hardware sentiment, so a failed bounce would weigh on the whole Nasdaq.
8. AST SpaceMobile (ASTS) | Deutsche Bank Upgrade | Last Verified Close $50.97 (Oct. 9)
Down 62% From the May Peak, and Deutsche Bank Says Buy
Catalyst: Deutsche Bank upgraded ASTS to Buy with a $93 target (+82%), arguing Friday’s SpaceX-driven drop was overdone.
Latest news: Shares fell 10% Friday after SpaceX agreed to buy a nationwide spectrum portfolio, then rose about 5% to near $53.44 on Monday. See the SpaceX spectrum fallout in TNN’s prior list.
Technicals: A new 52-week low printed Oct. 9; the stock sits ~62% below its May 28 high.
Fundamentals: Analysts expect revenue to grow from $70.9M in 2025 to $1.73B in 2028, but loss estimates widened.
| Metric | Data |
|---|---|
| Last verified close | $50.97 (Oct. 9); Oct. 12 intraday ~$53.44 (+4.9%) |
| 52-week range | ~$49 – $133.86 |
| Market cap | ~$20B (share-count dependent) |
| P/E / Dividend | n/a (loss-making) / None |
| Volume vs. average | n/v / ~10.2M average |
| YTD | About -26% (before Monday’s bounce) |
| Beta | ~2.7 |
| Analysts | Hold (about 14 analysts); average target ~$84.58 |
| Support (S1 / S2 / S3) | $50.97 / ~$49 / $45 |
| Resistance (R1 / R2 / R3) | $53.44 / $58.44 / $65 |
Bull case: Spectrum value, T-Mobile and government catalysts, and a depressed price.
Bear case: SpaceX becomes a direct rival, the $93 target implies ~80x forward sales and several brokers cut ratings in October.
What to watch:
- Holding $50.97 after the bounce
- Carrier and government headlines
- Any SpaceX financing or spectrum details
Forecast: A close above $53.44 opens $58.44. Losing $49 invites $45.
Why this matters: ASTS is the high-beta bet on whether satellite direct-to-phone survives SpaceX.
9. Sable Offshore (SOC) | JPMorgan Initiation | Reported Near $3.73 (+0.27%)
A Small-Cap Oil Restart Trading 82% Below Its High
Catalyst: JPMorgan initiated Sable at Overweight with a $10 target, roughly 175% above the price, and William Blair followed at Outperform.
Latest news: Sable finished Platform Hondo reconstruction and commissioning, and management expects final approval in October with a Q4 restart. Oct. 12 data is from Vista Partners and is not an official close.
Technicals: The stock bounced from a $3.28 low on Oct. 1 and remains below its 200-day average.
Fundamentals: The company is pre-profit with a market value below $1B.
| Metric | Data |
|---|---|
| Last price / change | ~$3.73 (+0.27%, per Vista Partners; unverified close) |
| 52-week range | $2.88 – $20.74 |
| Market cap | ~$0.6B – $0.7B |
| P/E / Dividend | Negative / None |
| Volume vs. average | n/v |
| Versus 52-week high | About -82% |
| Analysts | Hold consensus; average target ~$11.40 |
| Support (S1 / S2 / S3) | $3.59 / $3.28 / $2.88 |
| Resistance (R1 / R2 / R3) | $4.00 / $4.71 / ~$5.50 |
Bull case: Hondo restart would lift output, with targets of $8 – $10 and fresh coverage.
Bear case: Approval is not final, Q3 volumes were soft, one broker trimmed its target and the stock is extremely volatile.
What to watch:
- Regulatory approval for Hondo
- Oil sales volume updates
- A close above $4.00 on volume
Forecast: Approval news could drive a squeeze toward $4.71. A break under $3.28 retests $2.88.
Why this matters: SOC is a binary regulatory and execution story that can move 10% in a day.
10. CCC Intelligent Solutions (CCC) | Buyout Talks | Closed $7.59 (+8.12%)
Two Suitors, a Possible Rival Bid and a Deal “As Soon as Next Week”
Catalyst: Bloomberg reported GTCR and Elliott are in advanced talks to acquire CCC, with a deal possible as soon as next week, though talks could collapse or a rival could emerge.
Latest news: CCC rose 7% Friday and 8.12% Monday on 34.0M shares, about 3x its average. Copart was earlier reported to be interested.
Technicals: The stock cleared its prior $7.02 close and tagged ~$7.71 intraday.
Fundamentals: CCC supplies cloud and AI software to auto insurers and repairers with steady recurring revenue.
| Metric | Data |
|---|---|
| Last close / prior close | $7.59 (+$0.57, +8.12%) / $7.02 |
| Intraday high | ~$7.71 |
| 52-week range | n/v |
| Market cap | ~$4.2B |
| P/E / Dividend | n/v / None |
| Volume vs. average | 34.0M vs. 11.0M (about +208%) |
| YTD | About -17% |
| Analysts | n/v |
| Support (S1 / S2 / S3) | $7.02 / ~$6.57 / $6.00 |
| Resistance (R1 / R2 / R3) | $7.71 / $8.00 / $9.00 |
Bull case: A signed deal at a premium, plus a possible bidding war.
Bear case: No price is public, talks could fail and the stock would likely give back the run.
What to watch:
- A definitive agreement or press release
- Any rival bid
- Merger-arb spread once terms appear
Forecast: Confirmed terms could set a new anchor above $8.00. A collapse of talks risks a drop to $7.02 – $6.57.
Why this matters: Takeover chatter on beaten-down software names has become one of the market’s most reliable catalysts.
Sector Sentiment Snapshot and Forecast
| Sector | Sentiment | Driver |
|---|---|---|
| Financials | Cautious | Earnings test amid 5.24% yields |
| Memory / semis | Fragile | CXMT competition, three-day slide |
| AI infrastructure | Mixed | IREN rumor versus execution doubts |
| Software | Improving | BofA’s AI reversal |
| Healthcare insurers | Event-driven | UNH guidance and the ratio |
| Small caps / event-driven | Selective | Russell 2000 down 0.45% |
Sector forecast: Expect large moves on Tuesday morning from bank and UNH prints, then CPI on Wednesday. Memory and AI infrastructure remain headline-driven. Small caps with real catalysts (SOC, CCC) can outperform in a weak Russell. Our Oct. 7 setups show how fast these themes rotate.
Stocks to Watch Tomorrow: At a Glance
| # | Stock | Last Close | Move | Catalyst | Key Support | Key Resistance |
|---|---|---|---|---|---|---|
| 1 | JPM | $334.30 | +0.39% | Q3 earnings, before open | $325 | $345 |
| 2 | GS | $893.95 | -0.15% | Q3 earnings, before open | $868.52 | $905 – $913 |
| 3 | UNH | $378.52 | -0.21% | Q3 earnings, guidance | $373.67 | $404 |
| 4 | IREN | $34.80 | -1.11% | Anthropic report | $34.64 | $38.35 |
| 5 | IONQ | $36.27 | -9.07% | $1.3B Elisity deal | $35.89 | $39.89 |
| 6 | CRM | $233.92 | +2.09% | BofA double upgrade | $229.13 | $240.90 |
| 7 | MU | $989.04 | -3.88% | CXMT memory selloff | $984 | $1,029 |
| 8 | ASTS | $50.97 (Oct. 9) | ~+5% Oct. 12 | Deutsche Bank upgrade | $49 | $53.44 |
| 9 | SOC | ~$3.73 | +0.27% | JPM initiation, Hondo | $3.28 | $4.00 |
| 10 | CCC | $7.59 | +8.12% | Buyout talks | $7.02 | $8.00 |
Follow TNN for daily stock market news and financial news today.
Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss, and small-cap, event-driven, high-volatility stocks carry elevated risk. Stock prices, percentage moves, and market data cited reflect figures available at the time of publication and are subject to change as trading continues. Reports of corporate transactions and customer relationships may not be confirmed by the companies involved. Support and resistance levels are analytical zones, not predictions. Analyst price targets and ratings are third-party estimates and do not guarantee actual results. Always complete independent due diligence prior to executing equity trades.
About The Author
